These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15597221)

  • 1. Drug-resistant tuberculosis in HIV-infected persons: Italy 1999-2000.
    Vanacore P; Koehler B; Carbonara S; Zacchini F; Bassetti D; Antonucci G; Ippolito G; Girardi E;
    Infection; 2004 Dec; 32(6):328-32. PubMed ID: 15597221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tuberculosis drug resistance in patients with HIV and tuberculosis in South India.
    Swaminathan S; Paramasivan CN; Ponnuraja C; Iliayas S; Rajasekaran S; Narayanan PR
    Int J Tuberc Lung Dis; 2005 Aug; 9(8):896-900. PubMed ID: 16104637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
    Angarano G; Carbonara S; Costa D; Gori A
    Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
    Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis in Thai prisons: magnitude, transmission and drug susceptibility.
    Sretrirutchai S; Silapapojakul K; Palittapongarnpim P; Phongdara A; Vuddhakul V
    Int J Tuberc Lung Dis; 2002 Mar; 6(3):208-14. PubMed ID: 11934138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy.
    Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W
    J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of drug-resistant tuberculosis: analysis of 11 countries.
    Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
    Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fast identification of rifampicin-and isoniazid resistance of M. Tuberculosis strains by the "TB-biochip" test system].
    Isakova ZhT
    Georgian Med News; 2008 May; (158):15-9. PubMed ID: 18560033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National anti-tuberculosis drug resistance survey, 2002, in Myanmar.
    Ti T; Lwin T; Mar TT; Maung W; Noe P; Htun A; Kluge HH; Wright A; Aziz MA; Paramasivan CN
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1111-6. PubMed ID: 17044203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
    El-Sayed Zaki M; Goda T
    Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid- and rifampin-resistant tuberculosis in San Diego County, California, United States, 1993-2002.
    LoBue PA; Moser KS
    Int J Tuberc Lung Dis; 2005 May; 9(5):501-6. PubMed ID: 15875920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
    Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.